ABCA3, a key player in neonatal respiratory transition and genetic disorders of the surfactant system

Donatella Peca, Renato Cutrera, Andrea Masotti, Renata Boldrini, Olivier Danhaive

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Genetic disorders of the surfactant system are rare diseases with a broad range of clinical manifestations, from fatal respiratory distress syndrome (RDS) in neonates to chronic interstitial lung disease (ILD) in children and adults. ABCA3 [ATP-binding cassette (ABC), subfamily A, member 3] is a lung-specific phospholipid transporter critical for intracellular surfactant synthesis and storage in lamellar bodies (LBs). Its expression is developmentally regulated, peaking prior to birth under the influence of steroids and transcription factors. Bi-allelicmutations of the ABCA3 gene represent the most frequent cause of congenital surfactant deficiency, indicating its critical role in lung function. Mutations affect surfactant lipid and protein processing and LBs' morphology, leading to partial or total surfactant deficiency. Approximately 200 mutations have been reported, most of which are unique to individuals and families, which makes diagnosis and prognosis challenging. Various types of mutations, affecting different domains of the protein, account in part for phenotype diversity. Disease-causing mutations have been reported in most coding and some non-coding regions of the gene, but tend to cluster in the first extracellular loop and the second nucleotide-binding domain (NBD), leading to defective glycosylation and trafficking defects and interfering with ATP binding and hydrolysis respectively. Mono-allelic damaging and benign variants are often subclinical but may act as diseasemodifiers in lung diseases such as RDS of prematurity or associate withmutations in other surfactantrelated genes. Diagnosis is complex but essential and should combine pathology and ultrastructure studies on lung biopsy with broad-spectrum genetic testing of surfactant-related genes, made possible by recent technology advances in the massive parallel sequencing technology.

Original languageEnglish
Pages (from-to)913-919
Number of pages7
JournalBiochemical Society Transactions
Volume43
DOIs
Publication statusPublished - Oct 1 2015

Fingerprint

Inborn Genetic Diseases
Surface-Active Agents
Genes
Pulmonary diseases
Mutation
Lung
Adenosine Triphosphate
Technology
Glycosylation
Biopsy
Interstitial Lung Diseases
Genetic Testing
Pathology
Rare Diseases
Lung Diseases
Hydrolysis
Phospholipids
Proteins
Transcription Factors
Nucleotides

Keywords

  • Genetics
  • Interstitial lung disease
  • Neonate
  • Respiratory distress syndrome
  • Surfactant
  • Ultrastructure

ASJC Scopus subject areas

  • Biochemistry

Cite this

ABCA3, a key player in neonatal respiratory transition and genetic disorders of the surfactant system. / Peca, Donatella; Cutrera, Renato; Masotti, Andrea; Boldrini, Renata; Danhaive, Olivier.

In: Biochemical Society Transactions, Vol. 43, 01.10.2015, p. 913-919.

Research output: Contribution to journalArticle

@article{234f9f963c024d4cb6b7d016100e7d6f,
title = "ABCA3, a key player in neonatal respiratory transition and genetic disorders of the surfactant system",
abstract = "Genetic disorders of the surfactant system are rare diseases with a broad range of clinical manifestations, from fatal respiratory distress syndrome (RDS) in neonates to chronic interstitial lung disease (ILD) in children and adults. ABCA3 [ATP-binding cassette (ABC), subfamily A, member 3] is a lung-specific phospholipid transporter critical for intracellular surfactant synthesis and storage in lamellar bodies (LBs). Its expression is developmentally regulated, peaking prior to birth under the influence of steroids and transcription factors. Bi-allelicmutations of the ABCA3 gene represent the most frequent cause of congenital surfactant deficiency, indicating its critical role in lung function. Mutations affect surfactant lipid and protein processing and LBs' morphology, leading to partial or total surfactant deficiency. Approximately 200 mutations have been reported, most of which are unique to individuals and families, which makes diagnosis and prognosis challenging. Various types of mutations, affecting different domains of the protein, account in part for phenotype diversity. Disease-causing mutations have been reported in most coding and some non-coding regions of the gene, but tend to cluster in the first extracellular loop and the second nucleotide-binding domain (NBD), leading to defective glycosylation and trafficking defects and interfering with ATP binding and hydrolysis respectively. Mono-allelic damaging and benign variants are often subclinical but may act as diseasemodifiers in lung diseases such as RDS of prematurity or associate withmutations in other surfactantrelated genes. Diagnosis is complex but essential and should combine pathology and ultrastructure studies on lung biopsy with broad-spectrum genetic testing of surfactant-related genes, made possible by recent technology advances in the massive parallel sequencing technology.",
keywords = "Genetics, Interstitial lung disease, Neonate, Respiratory distress syndrome, Surfactant, Ultrastructure",
author = "Donatella Peca and Renato Cutrera and Andrea Masotti and Renata Boldrini and Olivier Danhaive",
year = "2015",
month = "10",
day = "1",
doi = "10.1042/BST20150100",
language = "English",
volume = "43",
pages = "913--919",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",

}

TY - JOUR

T1 - ABCA3, a key player in neonatal respiratory transition and genetic disorders of the surfactant system

AU - Peca, Donatella

AU - Cutrera, Renato

AU - Masotti, Andrea

AU - Boldrini, Renata

AU - Danhaive, Olivier

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Genetic disorders of the surfactant system are rare diseases with a broad range of clinical manifestations, from fatal respiratory distress syndrome (RDS) in neonates to chronic interstitial lung disease (ILD) in children and adults. ABCA3 [ATP-binding cassette (ABC), subfamily A, member 3] is a lung-specific phospholipid transporter critical for intracellular surfactant synthesis and storage in lamellar bodies (LBs). Its expression is developmentally regulated, peaking prior to birth under the influence of steroids and transcription factors. Bi-allelicmutations of the ABCA3 gene represent the most frequent cause of congenital surfactant deficiency, indicating its critical role in lung function. Mutations affect surfactant lipid and protein processing and LBs' morphology, leading to partial or total surfactant deficiency. Approximately 200 mutations have been reported, most of which are unique to individuals and families, which makes diagnosis and prognosis challenging. Various types of mutations, affecting different domains of the protein, account in part for phenotype diversity. Disease-causing mutations have been reported in most coding and some non-coding regions of the gene, but tend to cluster in the first extracellular loop and the second nucleotide-binding domain (NBD), leading to defective glycosylation and trafficking defects and interfering with ATP binding and hydrolysis respectively. Mono-allelic damaging and benign variants are often subclinical but may act as diseasemodifiers in lung diseases such as RDS of prematurity or associate withmutations in other surfactantrelated genes. Diagnosis is complex but essential and should combine pathology and ultrastructure studies on lung biopsy with broad-spectrum genetic testing of surfactant-related genes, made possible by recent technology advances in the massive parallel sequencing technology.

AB - Genetic disorders of the surfactant system are rare diseases with a broad range of clinical manifestations, from fatal respiratory distress syndrome (RDS) in neonates to chronic interstitial lung disease (ILD) in children and adults. ABCA3 [ATP-binding cassette (ABC), subfamily A, member 3] is a lung-specific phospholipid transporter critical for intracellular surfactant synthesis and storage in lamellar bodies (LBs). Its expression is developmentally regulated, peaking prior to birth under the influence of steroids and transcription factors. Bi-allelicmutations of the ABCA3 gene represent the most frequent cause of congenital surfactant deficiency, indicating its critical role in lung function. Mutations affect surfactant lipid and protein processing and LBs' morphology, leading to partial or total surfactant deficiency. Approximately 200 mutations have been reported, most of which are unique to individuals and families, which makes diagnosis and prognosis challenging. Various types of mutations, affecting different domains of the protein, account in part for phenotype diversity. Disease-causing mutations have been reported in most coding and some non-coding regions of the gene, but tend to cluster in the first extracellular loop and the second nucleotide-binding domain (NBD), leading to defective glycosylation and trafficking defects and interfering with ATP binding and hydrolysis respectively. Mono-allelic damaging and benign variants are often subclinical but may act as diseasemodifiers in lung diseases such as RDS of prematurity or associate withmutations in other surfactantrelated genes. Diagnosis is complex but essential and should combine pathology and ultrastructure studies on lung biopsy with broad-spectrum genetic testing of surfactant-related genes, made possible by recent technology advances in the massive parallel sequencing technology.

KW - Genetics

KW - Interstitial lung disease

KW - Neonate

KW - Respiratory distress syndrome

KW - Surfactant

KW - Ultrastructure

UR - http://www.scopus.com/inward/record.url?scp=84947283829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947283829&partnerID=8YFLogxK

U2 - 10.1042/BST20150100

DO - 10.1042/BST20150100

M3 - Article

C2 - 26517903

AN - SCOPUS:84947283829

VL - 43

SP - 913

EP - 919

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

ER -